| Serial Number | 99279709 |
| Word Mark | NUVAXOVID |
| Filing Date | Friday, July 11, 2025 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Tuesday, December 9, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 30, 2025 |
| Goods and Services | Providing medical and scientific research information in the field of Covid-19 vaccines, and clinical trials and post-market trials related to Covid-19 vaccines; consulting services in the field of research and development of Covid-19 vaccines; Covid-19 vaccine research and development |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, July 11, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Novavax, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Gaithersburg, MD 20878 |
| Event Date | Event Description |
| Friday, July 11, 2025 | APPLICATION FILING RECEIPT MAILED |
| Friday, July 11, 2025 | NEW APPLICATION ENTERED |
| Monday, November 17, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, December 1, 2025 | ASSIGNED TO EXAMINER |
| Tuesday, December 2, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, December 24, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |